| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/09/2009 | CN101596256A Formulation of weight reducing tea |
| 12/09/2009 | CN101596233A Medicine composition used for preventing birth defects and improving memories |
| 12/09/2009 | CN101596216A Microbiological preparation for preventing or treating diabetes and related symptoms |
| 12/09/2009 | CN101596214A Drug combination for reducing blood sugar and lipid levels |
| 12/09/2009 | CN101596213A Drug combination for reducing blood sugar and lipid levels |
| 12/09/2009 | CN101596212A Drug combination for reducing blood sugar and lipid levels |
| 12/09/2009 | CN101596211A Drug combination for reducing blood sugar and lipid levels |
| 12/09/2009 | CN101596210A Drug combination for reducing blood sugar and lipid levels |
| 12/09/2009 | CN101596209A Drug combination for reducing blood sugar and lipid levels |
| 12/09/2009 | CN101596203A Application of syringin in preparing drugs for treating cardiovascular and cerebrovascular diseases |
| 12/09/2009 | CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor |
| 12/09/2009 | CN101596180A Plant amino acid type chelated calcium, iron and zinc composition and preparation method thereof |
| 12/09/2009 | CN101596169A Chitosan nanoparticle for encapsulating adenosine triphosphate and preparation method thereof |
| 12/09/2009 | CN101596001A Natural egg for activating blood and nourishing the heart and preparation method thereof |
| 12/09/2009 | CN101595980A Multicolored hypoglycemic tea drink containing fruits and vegetables and preparation method thereof |
| 12/09/2009 | CN101595927A Natural tea for nourishing entrails and reducing blood fat, blood sugar and blood pressure and preparation method thereof |
| 12/09/2009 | CN101595925A Gastrodia tuber antihypertensive tea and preparation method thereof |
| 12/09/2009 | CN100567483C FAD4, FAD5, FAD5-2 and FAD6 fatty acid desaturase enzyme family members and uses thereof |
| 12/09/2009 | CN100567322C Polypeptide for inhibiting growth differentiation factor activity and cell expressing the same |
| 12/09/2009 | CN100567309C (E)3,5-di-methoxy-diphenylene-4'-0-phosphates (salt) and its preparing method, medicine composition and use |
| 12/09/2009 | CN100567276C Tri(cyclo) substituted amide compounds |
| 12/09/2009 | CN100567270C Sulfonyl amide derivatives |
| 12/09/2009 | CN100567266C Cannabinoid receptor ligands |
| 12/09/2009 | CN100567253C Novel succinate salt of O-demethyl-venlafaxine |
| 12/09/2009 | CN100567252C Fenfluramine hydrochloride raw material drug and tablet and its preparing method |
| 12/09/2009 | CN100566730C Method of preparing tea for lowering blood pressure and lowering blood fat |
| 12/09/2009 | CN100566728C Method for extracting bitter buckwheat flavone in high purity |
| 12/09/2009 | CN100566723C Carbohydrase inhibitors derived from chestnut and use thereof |
| 12/09/2009 | CN100566717C Composition for treating hyperlipemia |
| 12/09/2009 | CN100566716C Composition for treating hyperlipemia |
| 12/09/2009 | CN100566591C Bait used specially for atlantic trout |
| 12/08/2009 | US7629471 Transcriptional factor, process for producing the same and use thereof |
| 12/08/2009 | US7629468 Neuroprotectants, analgesics or anticonvulsants |
| 12/08/2009 | US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 12/08/2009 | US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 12/08/2009 | US7629363 Diaryl substituted pyridinones |
| 12/08/2009 | US7629362 2-pyridine carboxamide derivatives |
| 12/08/2009 | US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/08/2009 | US7629341 Human ADAM-10 inhibitors |
| 12/08/2009 | US7629337 Chemokine receptor binding heterocyclic compounds |
| 12/08/2009 | US7629318 Immunosuppressant compounds, methods and uses related thereto |
| 12/08/2009 | US7629168 Reversibly immortalized human pancreatic islet cell line containing an hTERT gene and an SV40T gene each interposed between a pair of LoxP sequences, characterized in that it is capable of producing insulin and enhancing expression of insulin after excising the hTERT gene and the SV40T gene, NAKT-13 |
| 12/08/2009 | US7629144 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 12/08/2009 | US7629014 Defatted canola flake, protein, and phytate; isoelectric precipitation and/or ultrafiltration |
| 12/08/2009 | US7629005 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 12/08/2009 | US7628988 Induce cell differentiation; process control |
| 12/08/2009 | US7628983 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide |
| 12/08/2009 | US7628981 Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 12/08/2009 | CA2510797C Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/08/2009 | CA2440744C Il-12 expression controlling agent |
| 12/08/2009 | CA2422354C Pyrazole compounds useful as protein kinase inhibitors |
| 12/08/2009 | CA2419301C Quinazoline derivatives |
| 12/08/2009 | CA2404725C Extrusion die |
| 12/08/2009 | CA2404005C Composition comprising free amino acids |
| 12/08/2009 | CA2398794C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 12/08/2009 | CA2374898C Pyrazinyl-piperazine compounds, their use and preparation |
| 12/08/2009 | CA2370230C Treatment of systemic lupus erythematosis |
| 12/08/2009 | CA2359242C Growth differentiation factor inhibitors and uses therefor |
| 12/08/2009 | CA2355075C Heteroaryl-cyclic acetals |
| 12/08/2009 | CA2329046C Composition comprising l-ascorbic acid and pectin |
| 12/08/2009 | CA2315113C Pyridones as src family sh2 domain inhibitors |
| 12/08/2009 | CA2314613C Azolo triazines and pyrimidines |
| 12/08/2009 | CA2234398C Composition and method for providing nutrition to diabetics |
| 12/08/2009 | CA2202016C Process for the production of lipstatin and of tetrahydrolipstatin |
| 12/08/2009 | CA2136871C Composition and method for inducing satiety |
| 12/03/2009 | WO2009146358A1 Imidazopyridine and related analogs as sirtuin modulators |
| 12/03/2009 | WO2009146102A1 Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances |
| 12/03/2009 | WO2009145363A1 Composition comprising a hot water extract of hemerocallis plants, said composition being effective in treating fatigue by having antidepressant properties or by improving sleep |
| 12/03/2009 | WO2009145238A1 Immunomodulatory agent and use thereof |
| 12/03/2009 | WO2009144961A1 Substituted carbinol compound having cyclic linker |
| 12/03/2009 | WO2009144929A1 New crystalline pyrithione/zinc oxide complex and physiologic/antibiotic active composite containing the same |
| 12/03/2009 | WO2009144555A1 Pyrazolospiroketone acetyl-coa carboxylase inhibitors |
| 12/03/2009 | WO2009144554A1 Pyrazolospiroketone acetyl-c0a carboxylase inhibitors |
| 12/03/2009 | WO2009144467A1 Composition comprising 1, 3 /1, 6 beta glucan for reducing weight |
| 12/03/2009 | WO2009144432A1 Mc4-r agonists for the treatment of obesity |
| 12/03/2009 | WO2009144278A2 USES OF CONGLUTIN-γ |
| 12/03/2009 | WO2009144268A1 Composition for increasing gastrointestinal transit time |
| 12/03/2009 | WO2009143763A1 The use of tanshinone iia in preparing medicine for treating obesity and insulin resistance |
| 12/03/2009 | WO2009143619A1 Methods of treating or preventing obesity and obesity-related hypertension |
| 12/03/2009 | WO2009143565A1 Method of diagnosis of infection by mycobacteria and reagents therefor |
| 12/03/2009 | WO2009121945A3 Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
| 12/03/2009 | WO2009108657A3 Heteroaryl derivatives as cftr modulators |
| 12/03/2009 | WO2009099988A3 Method and apparatus for fat removal |
| 12/03/2009 | WO2009043479A3 Use of eaa-mart1 (26-35) for the treatment of human cytomegalovirus infections |
| 12/03/2009 | WO2009043478A3 Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections |
| 12/03/2009 | WO2009035473A3 Method of treating binge eating disorder, obesity resulting from binge eating behavior and depressive disorders |
| 12/03/2009 | WO2009024429A3 Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria |
| 12/03/2009 | US20090298943 Use of creatine analogues and creatine kinase modulators for the prevention and treatment of obesity and its related disorders |
| 12/03/2009 | US20090298941 Anti-adipocyte fatty acid-binding protein (ap2), anti-flap and anti-cyslt1 receptor herbal compositions |
| 12/03/2009 | US20090298896 Activating agent for peroxisome proliferator activated receptor delta |
| 12/03/2009 | US20090298895 Use of thioproline in body weight reduction treatments |
| 12/03/2009 | US20090298886 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors |
| 12/03/2009 | US20090298883 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 12/03/2009 | US20090298876 Modulators of atp-binding cassette transporters |
| 12/03/2009 | US20090298856 2,3 Substituted fused bicyclic pyrimidin-4(3H)-ones modulating the function of the vanilliod-1receptor (VR1) |
| 12/03/2009 | US20090298854 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 12/03/2009 | US20090298853 Carbamoyl Compounds as DGAT1 Inhibitors 190 |
| 12/03/2009 | US20090298841 serotonin receptor modulators such as 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline, used for treating obesity, nervous system disorders such as dementia, schizophrenia and Alzheimer's disease, and as cognition activators |
| 12/03/2009 | US20090298829 Melanocortin receptor agonists |
| 12/03/2009 | US20090298796 Reducing risk of type 2 diabetes (t2d) |